CyberKnife® Hero


A non-surgical alternative to traditional cancer treatments

New call-to-action

Imagine a nonsurgical way to treat both cancerous and noncancerous tumors anywhere in the body, including the brain, liver, kidney, neck, spine, lung, pancreas and prostate. Now imagine that it were pain-free and caused fewer side effects than did other treatments. The CyberKnife® Robotic Stereotactic Radiosurgery System makes all that a reality.

What is CyberKnife?

CyberKnife is the only robotic radiosurgery system that can deliver non-surgical stereotactic treatments with sub-millimeter accuracy, anywhere in the body — including the prostate, lung, brain, spine, liver, pancreas and kidneys. It delivers beams of high-dose radiation with pinpoint accuracy allowing for efficient highly effective treatments without patient discomfort.

CyberKnife is an advanced technology that delivers a specialized form of radiation therapy called stereotactic radiosurgery (SRS), or stereotactic body radiation therapy(SBRT). It is comprised of a compact linear accelerator, a machine that generates a radiation beam, attached to a highly maneuverable robotic arm.

The CyberKnife features a device that controls the width of the radiation beams the machine delivers during treatment, allowing our clinical experts to vary the beam size and treat a larger variety of tumors throughout the body.

During CyberKnife procedures, patients will lie on a treatment table while the machine’s robotic arm moves around their body delivering high doses of radiation directly to their tumor with pinpoint precision. The cumulative dose of radiation delivered by the CyberKnife kills tumor cells while minimizing exposure to surrounding healthy tissue.
Most treatment sessions typically last 30 – 90 minutes depending on the size, shape and location of your tumor. 

Why Choose CyberKnife?     

  • Noninvasive, no incisions
  • No anesthesia or hospitalization required
  • Painless treatment
  • Five or fewer outpatient treatment sessions
  • Little to no recovery time
  • Immediate return to daily activities
  • Few side effects and minimal radiation exposure to healthy tissue surrounding a tumor 
  • Covered by Medicare and most private insurance companies 
Candidates for CyberKnife
  • Those who seek an alternative to surgery or conventional radiation therapy.
  • Recurrent cancer or metastatic tumors that have spread to other areas of the body from the main tumor site.
  • A high risk of developing complications after surgery.
  • Those who are unable to undergo surgery due to other health complications.

Learn More

Subscribe to Our Newsletter

Subscribe to the Saint Peter's Better Health newsletter and receive the latest health news, community events, recipes, and more.

Support Saint Peter’s

Your gift of any size directly impacts the patients who are cared for at Saint Peter's. Donate TodayLearn More